American International Group Inc. grew its position in 2seventy bio, Inc. (NASDAQ:TSVT – Free Report) by 34.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,175 shares of the company’s stock after purchasing an additional 6,130 shares during the quarter. American International Group Inc.’s holdings in 2seventy bio were worth $245,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of TSVT. Metropolitan Life Insurance Co NY bought a new position in 2seventy bio during the first quarter worth $25,000. Ameritas Investment Partners Inc. bought a new position in 2seventy bio during the first quarter worth $30,000. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in 2seventy bio during the second quarter worth $33,000. Group One Trading L.P. bought a new position in 2seventy bio during the first quarter worth $69,000. Finally, Cubist Systematic Strategies LLC increased its position in 2seventy bio by 896.6% during the first quarter. Cubist Systematic Strategies LLC now owns 4,106 shares of the company’s stock worth $42,000 after acquiring an additional 3,694 shares during the period. Institutional investors own 98.49% of the company’s stock.
2seventy bio Stock Performance
Shares of NASDAQ:TSVT opened at $1.74 on Tuesday. 2seventy bio, Inc. has a 52 week low of $1.65 and a 52 week high of $16.17. The company’s fifty day moving average is $3.35 and its 200-day moving average is $7.14. The company has a market capitalization of $88.09 million, a PE ratio of -0.45 and a beta of 1.49.
Wall Street Analysts Forecast Growth
2seventy bio Profile
2seventy bio, Inc, a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and chimeric antigen receptor-T cell product candidates for the treatment of multiple myeloma.
- Five stocks we like better than 2seventy bio
- Stock Average Calculator
- The most upgraded stocks in November have two things in common
- What Is WallStreetBets and What Stocks Are They Targeting?
- Monday.com rocked earnings like it’s the weekend
- What Does Downgrade Mean in Investing?
- Plan to own one retailer? Make it this one
Receive News & Ratings for 2seventy bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 2seventy bio and related companies with MarketBeat.com's FREE daily email newsletter.